Lilly Stock Jumps After Phase 3 Weight-Drug Readout
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Using index funds for stock diversification can simplify your investment strategy. Explore how they can provide broad market exposure.
23,126 articlesLilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
A late-life stock decision can shape a family's tax bill for years. By holding appreciated stock until death, heirs m...
JPMorgan backs Broadcom with an aggressive-buy stance, citing AI momentum and packaging strength as reasons to buy th...
Ark Invest discloses a fresh Palantir stake as AI momentum collides with higher yields, prompting debate over whether...
Micron's memory leadership and AI-ready HBM4 shipments clash with Intel's restructuring effort and foundry bets. As A...
As 2026 unfolds, investors must weigh software-driven growth against hardware resilience. This guide compares Salesfo...
The founder is back at Simply Good Foods, triggering a shift in market mood as insiders buy and Reddit chatter tilts ...
Cogent is moving from fading legacy lines to wavelength services for AI infrastructure, yet its stock remains under p...
Backlogs can unlock revenue visibility, but they can also mask quality issues. This article explains how to assess or...
What happened in Designer Brands (DBI) 2025 earnings, and what it means for investors in 2026. This guide breaks down...
As investors digest Karyopharm's Q1 2026 earnings, this guide breaks down what to watch, how to interpret the numbers...
Two tech giants reported divergent Q1 results as they sprint into AI. Meta dominates ads but burns cash on Reality La...